| Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ... Journal of the American college of cardiology 76 (25), 2982-3021, 2020 | 5860 | 2020 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 5338 | 2020 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 570 | 2020 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 526 | 2020 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to … GBDC Collaboration JAMA oncology, 2019 | 524* | 2019 |
| The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017 LM Force, I Abdollahpour, SM Advani, D Agius, E Ahmadian, F Alahdab, ... The Lancet Oncology 20 (9), 1211-1225, 2019 | 310 | 2019 |
| Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 R Burstein, NJ Henry, ML Collison, LB Marczak, A Sligar, S Watson, ... Nature 574 (7778), 353-358, 2019 | 255 | 2019 |
| Systematic methodological evaluation of a multiplex bead-based flow cytometry assay for detection of extracellular vesicle surface signatures OPB Wiklander, RB Bostancioglu, JA Welsh, AM Zickler, F Murke, ... Frontiers in immunology 9, 1326, 2018 | 196 | 2018 |
| Identification of storage conditions stabilizing extracellular vesicles preparations A Görgens, G Corso, DW Hagey, R Jawad Wiklander, MO Gustafsson, ... Journal of extracellular vesicles 11 (6), e12238, 2022 | 113 | 2022 |
| Anemia prevalence in women of reproductive age in low-and middle-income countries between 2000 and 2018 D Kinyoki, AE Osgood-Zimmerman, NV Bhattacharjee, NJ Kassebaum, ... Nature medicine 27 (10), 1761-1782, 2021 | 91 | 2021 |
| Mapping routine measles vaccination in low-and middle-income countries Nature 589 (7842), 415-419, 2021 | 79 | 2021 |
| Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model B Bestas, PMD Moreno, KEM Blomberg, DK Mohammad, AF Saleh, ... The Journal of clinical investigation 124 (9), 4067-4081, 2014 | 74 | 2014 |
| Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant A Hamasy, Q Wang, KEM Blomberg, DK Mohammad, L Yu, M Vihinen, ... Leukemia 31 (1), 177-185, 2017 | 61 | 2017 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to … C Fitzmaurice, Global Burden of Disease Cancer Collaboration Journal of Clinical Oncology 36 (15_suppl), 1568-1568, 2018 | 55 | 2018 |
| TEC family kinases in health and disease–loss‐of‐function of BTK and ITK and the gain‐of‐function fusions ITK–SYK and BTK–SYK A Hussain, L Yu, R Faryal, DK Mohammad, AJ Mohamed, CIE Smith The FEBS journal 278 (12), 2001-2010, 2011 | 55 | 2011 |
| BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib HY Estupiñán, Q Wang, A Berglöf, GCP Schaafsma, Y Shi, L Zhou, ... Leukemia 35 (5), 1317-1329, 2021 | 51 | 2021 |
| Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles D Gupta, OPB Wiklander, A Görgens, M Conceição, G Corso, X Liang, ... Nature biomedical engineering 5 (9), 1084-1098, 2021 | 50 | 2021 |
| Anti‐leukaemic effects induced by APR‐246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute … D Ali, DK Mohammad, H Mujahed, K Jonson‐Videsäter, B Nore, C Paul, ... British journal of haematology 174 (1), 117-126, 2016 | 48 | 2016 |
| Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells DK Mohammad, BF Nore, A Hussain, MO Gustafsson, AJ Mohamed, ... Molecular and cellular biology 33 (16), 3214-3226, 2013 | 45 | 2013 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 GBD 2021 Anaemia Collaborators The Lancet Haematology 10 (9), e713-e734, 2023 | 42 | 2023 |
